List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 60 studies with search of: rsv
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed Phase 2 Study of ALN-RSV01 in Lung Transplant Patients Infected With Respiratory Syncytial Virus (RSV)
Condition: Respiratory Syncytial Virus Infections
Interventions: Drug: ALN-RSV01;   Drug: normal saline
2 Completed Intranasal ALN-RSV01 Administered to Adult Volunteers Experimentally Inoculated With Respiratory Syncytial Virus
Condition: Respiratory Syncytial Virus Infections
Intervention: Drug: ALN-RSV01
3 Completed Safety, Tolerability and Pharmacokinetic Study of Single and Multiple Intravenous Doses of RSV604 in Healthy Subjects.
Condition: Healthy
Intervention: Drug: RSV604
4 Completed A Study to Evaluate a Single IM Dose of Motavizumab Treatment of Children With RSV (Respiratory Syncytial Virus) Illness
Condition: Healthy
Interventions: Biological: MEDI-524;   Other: Placebo
5 Recruiting An Observational Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants
Condition: Healthy
Intervention:
6 Active, not recruiting A Study to Evaluate a Single Intravenous Dose of Motavizumab for the Treatment of Children Hospitalized With RSV Illness
Condition: Respiratory Syncytial Virus (RSV)
Interventions: Biological: Motavizumab;   Other: Biological/Vaccine: Motavizumab;   Other: Placebo
7 Recruiting RI-001 in Immunosuppressed Respiratory Syncytial Virus (RSV) Infected Patients at Risk of Lower Tract RSV Illness
Conditions: Upper Respiratory Tract Infection;   Lower Respiratory Tract Infection
Intervention: Biological: RI-001
8 Completed Study of MEDI-524 (Numax), for the Prophylaxis of Serious Respiratory Syncytial Virus (RSV) Disease in High-Risk Children
Condition: Respiratory Syncytial Virus Infections
Intervention: Drug: MEDI-524
9 Completed Study to Evaluate the Safety of MEDI-534 Vaccine Against Respiratory Syncytial Virus (RSV) and Parainfluenza Virus Type 3 (PIV3) in Healthy Children
Condition: Healthy
Intervention: Biological: MEDI-534
10 Active, not recruiting MEDI-524 (Motavizumab) for the Prevention of Respiratory Syncytial Virus (RSV) Disease Among Native American Indian Infants in the Southwestern United States
Condition: Healthy
Interventions: Biological: MEDI-524;   Other: Placebo
11 Completed A Study of the Safety and Efficacy of A-60444 in Adults With Respiratory Syncytial Virus (RSV) Infection Following Stem Cell Transplantation
Condition: Respiratory Syncytial Virus Infections
Intervention: Drug: A-60444
12 Terminated Acoustic Assessment of Nebulized Epinephrine Versus Albuterol for RSV Bronchiolitis- a Double Blind Study
Condition: Rsv Bronchiolitis
Intervention: Drug: nebulized epinephrine and nebulized albuterol
13 Recruiting TGV:Use of the Quick Diagnostic Test of the Influenza and the Infection With RSV by the Paediatric Emergency Unit
Conditions: Influenza;   Respiratory Syncytial Viruses
Intervention: Device: RSV respi-strip and Quick-vue influenza
14 Completed Prevention of RSV Infections in Bone Marrow Transplant Recipients
Condition: Respiratory Syncytial Virus Infection
Intervention: Drug: RSV Polyclonal Immunoglobulin
15 Completed Association Between Cytokines and Severity of Respiratory Syncytial Virus (RSV)-Induced Illness in the Elderly
Condition: Respiratory Syncytial Virus Infections
Intervention:
16 Completed Study of Motavizumab (MEDI-524) and Palivizumab in the Same Respiratory Syncytial Virus (RSV) Season
Conditions: Respiratory Syncytial Virus Infections;   Chronic Lung Disease
Intervention: Drug: MEDI-524
17 Completed Study to Evaluate the Incidence of Hospitalizations and Respiratory Tract Infections in Premature Infants
Condition: Respiratory Syncytial Virus Infections
Intervention:
18 Active, not recruiting Intermittent Use of Aerosolized Ribavirin for Treatment of RSV
Condition: Hematological Malignancies
Intervention: Drug: Ribavirin
19 Completed A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of a Single Intravenous Dose of MEDI-524, a Humanized Enhanced Potency Monoclonal Antibody to Respiratory Syncytial Virus (RSV), in Otherwise Healthy Children Hospitalized With RSV Infection
Condition: Respiratory Syncytial Virus Infections
Intervention: Biological: MEDI-524
20 Recruiting Innate Immunity and Respiratory Syncytial Virus (RSV) Infection in Children
Condition: Respiratory Syncytial Virus Infection
Intervention:

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services